Related Experiment Video
Updated: Feb 22, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
A household cluster of RSV infection causing severe pneumonia in a four-month-old infant
Chengcheng Wang1, Lingyu Shen1, Xiaofeng Wei2
1School of Public Health, Capital Medical University, Beijing 100069, China; Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Research Center for Respiratory Infectious Diseases, Beijing Center for Disease Prevention and Control, Beijing 100013, China.
Insights
Household transmission of respiratory syncytial virus (RSV) can lead to severe infant illness. Genetic mutations in the RSV strain may worsen symptoms, highlighting the importance of identifying household infectious sources for infants with severe RSV disease.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- Respiratory syncytial virus (RSV) is a primary cause of lower respiratory tract infections in infants.
- Severe RSV infections in infants necessitate understanding transmission dynamics and contributing factors.
Purpose of the Study:
- To analyze a household cluster of severe RSV infection.
- To identify potential infectious sources within households for targeted interventions.
- To evaluate the impact of RSV infection on immune responses and clinical outcomes.
Main Methods:
- Collection of clinical and epidemiological data.
- RT-qPCR for RSV detection.
- G gene and whole-genome sequencing for phylogenetic and mutation analysis.
Main Results:
- A four-member household experienced an RSV cluster, with an infant developing severe bronchiolitis and significant T-lymphocyte reductions.
- The RSV strain identified in the infant (B.D.E.1 lineage) showed close relation to a US strain with specific G gene mutations.
- Transmission occurred over 17 days, with household members serving as potential sources of infection.
Conclusions:
- Household members are a significant potential source of RSV infection for infants experiencing severe disease.
- Genetic mutations within the RSV strain may play a role in exacerbating clinical symptoms.
- Understanding household transmission is crucial for managing severe RSV cases in infants.
Objectives:
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in infants. We analyzed a household RSV cluster of severe RSV infection to inform targeted interventions and outcome evaluation.
Methods:
Clinical and epidemiological data were collected for characteristic analysis. Species of RSV positivity was confirmed by RT-qPCR; G gene and whole-genome sequencing were performed for phylogenetic and mutation analyses.
Results:
A household cluster affected four family members. In order of symptoms, the first case (Case A, 31-year-old postpartum woman) was diagnosed with pneumonia, the second case (Case B, a four-month-old male infant of Case A) developed severe bronchiolitis with hospitalization for 7 days, and receiving nebulization for 30 days. Final cases (Cases C and D, father and babysitter of Case B) developed mild upper respiratory tract infections. The period of transmission from first to final cases spanned 17 days. During hospitalization, Case B showed marked immune changes: CD3+, CD4+ naive, and CD4+ T lymphocytes were decreased by approximately 3-fold and 3.3-fold, respectively, while CD8+, CD8+ naive, CD8+ central memory (CM), and CD4+ CM T lymphocytes were reduced by 1.5-fold, 1.22-fold, 2.72-fold, and 1.8-fold. During the six-month follow-up, respiratory infections recurred monthly in first three months. The RSV strain of Case B was B.D.E.1 lineage, closely related to US strain (PQ117674.1, 99.76% similarity) and separated from location B.D.E.1 in 2023-2024 and contemporaneous seasons [with 59 nucleotides and 2 amino-acids (A10S, K219I) mutation in G gene].
Discussion:
For RSV infants with severe disease, household members are a potential key infectious source, and genetic mutations could contribute to the exacerbation of clinical symptoms.
More Related Videos
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
09:14An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Cycle: Exhalation
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment